SLAMF7 and clear cell renal carcinoma: In clear cell renal cell carcinoma, elevated SLAMF7 expression was associated with poor prognosis and a macrophage-dominant immune phenotype, indicating its potential as a therapeutic target to restore antitumor immunity [34].